Haemodynamic monitoring of patients with extracorporeal life support (ECLS) using minimally invasive predictive methods

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00035483

Enrollment

Registered

2024-11-21

Start date

2025-01-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiogenic shock with the need for temporary mechanical circulatory support OPS 8-852.3 temporary mechanical circulatory support with minimalized heart-lung-machine R57.0

Interventions

Group 1: Patients on ECLS-support with minimalinvasive hemodynamic Monitoring during weaning from ECLS-support with classic weaning protocoll Group 2: Patients on ECLS-support with minimalinvasive hem

Eligibility

Sex/Gender

All

Age

19 Years to No maximum

Inclusion criteria

Inclusion criteria: - Implantation of an ECLS due to cardiogenic shock - Completion of the 18th year of life, regardless of gender - Patient care to be set up before the start of ECLS weaning

Exclusion criteria

Exclusion criteria: - Primary right ventricular failure - Diseases that exclude therapy with ECLS

Design outcomes

Primary

Measure	Time frame
Comparison of previous haemodynamic monitoring with new methods of haemodynamic monitoring with regard to the safety and applicability of new weaning protocols supported by the decisions based on the measured haemodynamic parameters	—

Secondary

Measure	Time frame
Mortality, Morbidity, duration of ECLS-Weaning/ ECLS-therapy	—

Countries

Germany

Contacts

Public ContactAschraf El-Essawi

Universitätsmedizin Göttingen

aschraf.el-essawi@med.uni-goettingen.de+49 551 3964340

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026